Agreed it looks interesting.
Management owns significant stakes, much of which is in restricted shares with ROC and growth targets attached.
Has $3.2mm in NOLs as of 4/30, compared to $1.05mm in TTM operating income.
Largest customer is 49% of sales. It has little differentiation in its products from competitors.
The good news is things are looking optimistic for next year. Backlog is $12.6mm vs last year's $9.8mm. The stock may not have discounted the anticipated FY14 earnings, but I don't see any visibility beyond immediate backlog, do you?
News 
Market Data 
Discover 
